
Otitis media- Pipeline Insight, 2024
Description
Otitis media- Pipeline Insight, 2024
DelveInsight’s, “Otitis-media- Pipeline Insight, 2024” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Otitis-media pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Geography Covered
- Global coverage
Otitis-media: Overview
Otitis media is inflammation or infection located in the middle ear. Otitis media can occur as a result of a cold, sore throat, or respiratory infection. Middle ear infections are usually a result of a malfunction of the eustachian tube, a canal that links the middle ear with the throat area. The eustachian tube helps to equalize the pressure between the outer ear and the middle ear. When this tube is not working properly, it prevents normal drainage of fluid from the middle ear, causing a buildup of fluid behind the eardrum. When this fluid cannot drain, it allows for the growth of bacteria and viruses in the ear that can lead to acute otitis media. Different types of otitis media include the following: Acute otitis media. This middle ear infection occurs abruptly causing swelling and redness. Fluid and mucus become trapped inside the ear, causing the child to have a fever and ear pain. Otitis media with effusion. Fluid (effusion) and mucus continue to accumulate in the middle ear after an initial infection subsides. The child may experience a feeling of fullness in the ear and it may affect his or her hearing or may have no symptoms. Chronic otitis media with effusion. Fluid remains in the middle ear for a prolonged period or returns again and again, even though there is no infection. May result in difficulty fighting new infection and may affect the child's hearing. The following are the most common symptoms of otitis media. However, each child may experience symptoms differently. Symptoms may include: Unusual irritability, difficulty sleeping or staying asleep, tugging or pulling at one or both ears, fever, especially in infants and younger children, fluid draining from ear(s), loss of balance, hearing difficulties and ear pain. In addition to a complete medical history and physical examination, child's health care provider will inspect the outer ear(s) and eardrum(s) using an otoscope. Tympanometry is a test that can be performed in most health care providers' offices to help determine how the middle ear is functioning. It does not tell if the child is hearing or not, but helps to detect any changes in pressure in the middle ear. This is a difficult test to perform in younger children because the child needs to remain still and not cry, talk, or move. Treatment will depend on the type of otitis media.
""Otitis-media- Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Otitis-media pipeline landscape is provided which includes the disease overview and Otitis-media treatment guidelines. The assessment part of the report embraces, in depth Otitis-media commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Otitis-media collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Report Highlights
- The companies and academics are working to assess challenges and seek opportunities that could influence Otitis-media R&D. The therapies under development are focused on novel approaches to treat/improve Otitis-media.
This segment of the Otitis-media report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.
Otitis-media Emerging Drugs
- V 114: Merck & Co
- CMTX-301: Clarametyx Biosciences
- VAX-24: Vaxcyte
Further product details are provided in the report……..
Otitis-media: Therapeutic Assessment
This segment of the report provides insights about the different Otitis-media drugs segregated based on following parameters that define the scope of the report, such as:
- Major Players in Otitis-media
Phases
DelveInsight’s report covers around 7+ products under different phases of clinical development like
- Late stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
- Route of Administration
- Intra-articular
- Intraocular
- Intrathecal
- Intravenous
- Ophthalmic
- Oral
- Parenteral
- Subcutaneous
- Topical
- Transdermal
- Molecule Type
- Oligonucleotide
- Peptide
- Small molecule
- Product Type
Otitis-media: Pipeline Development Activities
The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Otitis-media therapeutic drugs key players involved in developing key drugs.
Pipeline Development Activities
The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Otitis-media drugs.
Otitis-media Report Insights
- Otitis-media Pipeline Analysis
- Therapeutic Assessment
- Unmet Needs
- Impact of Drugs
- Pipeline Product Profiles
- Therapeutic Assessment
- Pipeline Assessment
- Inactive drugs assessment
- Unmet Needs
Current Treatment Scenario and Emerging Therapies:
- How many companies are developing Otitis-media drugs?
- How many Otitis-media drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Otitis-media?
- What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Otitis-media therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Otitis-media and their status?
- What are the key designations that have been granted to the emerging drugs?
- Merck & Co
- Clarametyx Biosciences
- Vaxcyte
- CEOLIA Pharma
- NanoCarrier
- V 114
- CMTX-301
- VAX-24
- ENT 103
- VAX-XP
Table of Contents
60 Pages
- Introduction
- Executive Summary
- Otitis-media: Overview
- Causes
- Mechanism of Action
- Signs and Symptoms
- Diagnosis
- Disease Management
- Pipeline Therapeutics
- Comparative Analysis
- Therapeutic Assessment
- Assessment by Product Type
- Assessment by Stage and Product Type
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
- Otitis-media– DelveInsight’s Analytical Perspective
- Late Stage Products (Phase III)
- Comparative Analysis
- V 114: Merck & Co
- Product Description
- Research and Development
- Product Development Activities
- Drug profiles in the detailed report…..
- Mid Stage Products (Phase II)
- Comparative Analysis
- Drug name : Company name
- Product Description
- Research and Development
- Product Development Activities
- Drug profiles in the detailed report…..
- Early Stage Products (Phase I)
- Comparative Analysis
- Drug name : Company name
- Product Description
- Research and Development
- Product Development Activities
- Drug profiles in the detailed report…..
- Preclinical and Discovery Stage Products
- Comparative Analysis
- CMTX-301: Clarametyx Biosciences
- Product Description
- Research and Development
- Product Development Activities
- Drug profiles in the detailed report…..
- Inactive Products
- Comparative Analysis
- Otitis-media Key Companies
- Otitis-media Key Products
- Otitis-media- Unmet Needs
- Otitis-media- Market Drivers and Barriers
- Otitis-media- Future Perspectives and Conclusion
- Otitis-media Analyst Views
- Otitis-media Key Companies
- Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.